Form 6-K AnPac Bio-Medical Scienc For: Oct 03
- Wall Street ends sharply higher after Powell comments
- Salesforce (CRM) shares slide despite topping earnings, revenue expectations
- Fed's Powell: Rate hikes to slow, but adjustment just beginning
- Snowflake shares plunge 13% despite Q3 beat
- Market turmoil and economic decline, before recovery in 2023, says JPM's Kolanovic
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2022
Commission File Number: 001-39137
AnPac Bio-Medical Science Co., Ltd.
801 Bixing Street, Bihu County
Lishui, Zhejiang Province 323006
The People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
|Form 20-F x||Form 40-F ¨|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Amendments to Articles of Incorporation or Bylaws
AnPac Bio-Medical Science Co., Ltd. has adopted the Fourth Amended and Restated Memorandum and Articles of Association on May 19, 2022. The full text of the Fourth Amended and Restated Memorandum and Articles of Association is set forth in Exhibit 5.03 to this report
|5.03||Fourth Amended and Restated Memorandum and Articles of Association|
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|AnPac Bio-Medical Science Co., Ltd.|
|By:||/s/ Dr. Chris Chang Yu|
|Name:||Dr. Chris Chang Yu|
|Title:||Co-Chairman of the Board of Directors and Co-Chief Executive Officer|
Dated: October 3, 2022
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AnPac Announces Regaining Compliance with Nasdaq Listing Requirement
- SPEC Announces New Tools and Reduced Academic Pricing for SPEC CPU 2017 Benchmark Suite
- GDS Releases 2021 ESG Report
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!